Quince Therapeutics, Inc. (QNCX)

NASDAQ: QNCX · Real-Time Price · USD

32.41

+1.15 (3.68%)

At close: Aug 13, 2026, 4:00 PM EDT

32.50

+0.09 (0.28%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.16	5.81	6.21	20.75	44.58	69.72
Short-Term Investments	-	11.94	34.57	54.31	45.6	37.08
Cash & Short-Term Investments	18.16	17.75	40.78	75.06	90.18	106.8
Cash Growth	-42.52%	-56.47%	-45.66%	-16.77%	-15.56%	-20.19%
Other Current Assets	7.42	5.14	3.25	2.38	3.57	4.87
Total Current Assets	25.58	22.9	44.04	77.44	93.75	111.67
Net Property, Plant & Equipment	0.97	1.05	0.81	0.62	0.68	1.43
Other Intangible Assets	-	67.82	60.05	63.67	5.9	-
Goodwill	-	-	-	17.63	-	-
Long-Term Investments	-	-	-	-	3.58	19.93
Other Long-Term Assets	0.08	1.76	9.58	8.54	-	0.19
Total Assets	26.62	93.52	114.48	167.9	103.91	133.23

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.39	2.22	2.9	2.03	0.57	4.91
Accrued Expenses	3.38	10.61	4.38	3.44	2.5	9.31
Current Portion of Long-Term Debt	-	18.03	-	-	-	-
Other Current Liabilities	-	12.37	-	4.1	-	-
Total Current Liabilities	8.77	43.23	7.28	9.57	3.07	14.22
Long-Term Debt	-	-	14.32	13.43	-	-
Long-Term Leases	0.29	0.33	0.39	0.32	-	0.42
Other Long-Term Liabilities	1.89	85.68	62.34	59.49	0.25	-
Total Long-Term Liabilities	2.18	86.01	77.05	73.24	0.25	0.42
Total Liabilities	10.95	129.24	84.33	82.82	3.32	14.64

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.06	0.04	0.04	0.04	0.03
Additional Paid-in Capital	435.59	418.93	406.61	401.64	389.11	355.23
Accumulated Other Comprehensive Income	4.61	5.75	-0.04	3.05	-0.29	-0.08
Retained Earnings	-424.54	-460.45	-376.47	-319.64	-288.26	-236.6
Shareholders' Equity	15.67	-35.71	30.15	85.08	100.59	118.59
Total Liabilities & Equity	26.62	93.52	114.48	167.9	103.91	133.23

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.29	18.36	14.72	13.75	0	0.42
Net Cash (Debt)	17.87	-0.6	26.07	61.31	90.18	106.38
Net Cash Growth	12.04%	-	-57.48%	-32.02%	-15.23%	-20.38%
Net Cash Per Share	49.66	-2.41	120.52	3292.89	5384.49	7159.29
Book Value	15.67	-35.71	30.15	85.08	100.59	118.59
Book Value Per Share	43.55	-142.58	139.36	4569.85	6006.17	7980.62
Tangible Book Value	15.67	-103.53	-29.9	3.79	94.69	118.59
Tangible Book Value Per Share	43.55	-413.33	-138.22	203.40	5653.90	7980.62

SEC Filings: 10-K · 10-Q